Malaysian consensus statement on FDG PET-CT reporting format for lymphoma.
Teik Hin Tana, T H Wongb, Choo Hang Khooc, Thanuja Mahaletchumyd, C S Nge, M W Ghazalif
- aSunway Medical Centre, Nuclear Medicine Centre, Selangor, Malaysia
- bPantai Hospital Kuala Lumpur, Department of Nuclear Medicine, Kuala Lumpur, Malaysia. wthuat@gmail.com
- cPenang Adventist Hospital, Nuclear Medicine Centre, Pulau Pinang, Malaysia
- dUniversiti Kebangsaan Malaysia Medical Centre, Department of Molecular Imaging and Nuclear Medicine, Selangor, Malaysia
- ePantai Hospital Kuala Lumpur, Department of Nuclear Medicine, Kuala Lumpur, Malaysia
- fHospital Pulau Pinang, Department of Nuclear Medicine, Pulau Pinang, Malaysia
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Over the past decade, 18F-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PETCT) has emerged as an important imaging modality in the management of lymphoma. Since the introduction of Deauville scoring system (2009) and the Lymphoma Response Assessment Criteria (2014), clinicians are now sharing a common language in the management of lymphoma. In Malaysia, nearly a third of PET-CT request is related to lymphoma imaging. Though there are extensive publications regarding these scoring systems and assessment criteria for lymphoma, there are hardly any literature on the reporting format for the 18F-FDG PET-CT in this disease. The variable reporting formats have on many occasions caused confusion not only to the referring clinicians but also to nuclear medicine physicians. Thus, a working committee comprising experienced nuclear medicine physicians and haematologists in Malaysia have agreed and made a joint recommendation on the standard reporting format for 18F-FDG PET-CT in Lymphoma. This recommendation will minimize inter-observer discrepancies in reporting, facilitate the understanding of the report of the referring clinicians as well as facilitate counseling between patients and clinicians in the management of the disease.

